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Background: TDP-43 aggregates and mutations are observed in patients with ALS and FTLD.
Results: The equilibrium unfolding of the RRM domains reveals a highly populated intermediate in RRM2.
Conclusion:The stability of RRM2may result from a large hydrophobic cluster, and the intermediate state may be essential for
accessing the nuclear export sequence.
Significance: Accessing the RRM2 intermediate state can potentially propagate disease pathogenesis.
Pathological alteration of TDP-43 (TAR DNA-binding pro-
tein-43), a protein involved in variousRNA-mediated processes,
is a hallmark feature of the neurodegenerative diseases amyo-
trophic lateral sclerosis and frontotemporal lobar degeneration.
Fragments of TDP-43, composed of the second RNA recogni-
tion motif (RRM2) and the disordered C terminus, have been
observed in cytoplasmic inclusions in sporadic amyotrophic lat-
eral sclerosis cases, suggesting that conformational changes
involving RRM2 together with the disordered C terminus play a
role in aggregation and toxicity. The biophysical data collected
byCDand fluorescence spectroscopies reveal a three-state equi-
libriumunfoldingmodel forRRM2,with a partially folded inter-
mediate state that is not observed inRRM1. Strikingly, a portion
ofRRM2beginning at position 208,whichmimics a cleavage site
observed in patient tissues, increases the population of this
intermediate state. Mutually stabilizing interactions between
the domains in the tethered RRM1 and RRM2 construct reduce
the population of the intermediate state and enhance DNA/
RNA binding. Despite the high sequence homology of the two
domains, a network of large hydrophobic residues inRRM2pro-
vides a possible explanation for the increased stability of RRM2
compared with RRM1. The cluster analysis suggests that the
intermediate state may play a functional role by enhancing
access to the nuclear export signal contained within its
sequence. The intermediate state may also serve as a molecular
hazard linking productive folding and function with pathologi-
cal misfolding and aggregation that may contribute to disease.
Amyotrophic lateral sclerosis (ALS)2 is a highly debilitating
and progressive motor neuron disease affecting approximately
1–2 of 100,000 new people each year, with death occurring 2–5
years after onset (1). Only 10% of ALS cases have been linked to
genetic mutations in numerous genes (familial ALS), whereas
the remaining 90% of cases result from an unknown cause (spo-
radic ALS) (2). The pathological hallmark of ALS is the pres-
ence of ubiquitinated inclusions in the cytoplasm of surviving
spinalmotor neurons. In 2006, biochemical and immunological
approaches identified TAR DNA-binding protein 43 (TDP-43)
as a major protein found in post-mortem brain inclusions of
patients with both ALS and frontotemporal lobar degeneration
with ubiquitinated inclusions (FTLD-U), providing amolecular
connection between these diseases (3, 4). In the years since this
initial discovery, 50 different TDP-43 mutations in familial and
sporadic ALS patients have been identified (see the ALSOnline
Genetics Database), thereby underscoring a direct role for
TDP-43 in ALS pathogenesis. Related research has been rapid
(5), with numerous reports of mouse models, biomarkers, and
assays for testing disease progression and cellular function.
However, a molecular level understanding of how TDP-43may
lead to disease is still lacking (4), in part because of the poor
solubility of the full-length protein and its tendency to fragment
and aggregate.
TDP-43 is a 414-amino acid protein that contains two RNA
recognition motifs (RRMs), a nuclear localization sequence in
the N terminus, a nuclear export signal (NES) within RRM2,
and a C-terminal glycine-rich domain (accession no. Q13148,
UniProtKB/Swiss-Prot) (Fig. 1A). TDP-43 is ubiquitously
expressed and has been implicated to play a functional role in
many RNA processes, including gene transcription, splicing,
mRNAprocessing, andmRNA stability (6–8). TDP-43 is local-
ized in the nucleus in normal cells but redistributes to form
cytoplasmic aggregates composed of hyperphosphorylated and
ubiquitinated C-terminal fragments in diseased cells (9). As
inferred from studies of other protein aggregates involved in
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neurodegenerative diseases (10), TDP-43 aggregates may arise
from the population of non-native conformations that probably
drive the neurodegeneration directly through a gain-of-func-
tion or loss-of-functionmechanism. In these scenarios, the for-
mation and accumulation of TDP-43 aggregates generate tox-
icity or impair normal TDP-43 cellular function, resulting in
cell death. Mounting evidence supports a loss-of-function phe-
notype (11), where sequestration of functional protein into
cytoplasmic aggregates would limit the pool of available func-
tional nuclear TDP-43.
Several studies have demonstrated that both RRM2 and the
disorderedC terminus are required for aggregation and toxicity
(12–15). Examination of the domain architecture of TDP-43
suggests a possible interplay between structured and disor-
dered sequences that may play a key role in toggling between
appropriate biological function and dysfunction leading to dis-
ease (Fig. 1A). Computer algorithms developed for predicting
aggregation prone regions in unfolded polypeptide chains (16),
WALTZ and TANGO, both show a high propensity for aggre-
gation in RRM2 and the C terminus (Fig. 1A). The sequence-
based disorder predictor algorithm, PONDR (17, 18), predicts a
high degree of disorder in the C-terminal region of TDP-43.
The two RRMdomains share significant sequence (Fig. 1B) and
structural (Fig. 1,C andD) homology. TheNMR solution struc-
tures of the isolated RRM domains (Fig. 1, C and D) and the
tethered RRM domains (Fig. 1E) show an    structure for
each domain, composed of two repeating  motifs with an
extra -strand (4) inserted within the second  motif.
Together, these strands form an antiparallel -sheet across one
face of the RRM with the -helices docked on the opposite face.
AlthoughRRMdomainscanbindadiverse setof targets, including
RNA,DNA, andpeptides andother proteins (19, 20),most studies
on TDP-43 have focused on the role of the highly conserved phe-
nylalanine side chains in 3 for RNA recognition (21–23).
To understand how the conformations populated by the
RRM domains of TDP-43 may play a role in disease propaga-
tion, the equilibrium unfolding and RNA-binding properties of
the isolated and tethered RRM domains were probed by a pair
of complementary spectroscopic techniques. The results iden-
tified a novel intermediate state in the folding of the RRM2
domain. The population of this intermediate is increased in a
cleavage fragment but is reduced upon tethering to RRM1. The
intermediate state in RRM2 may serve as a molecular hazard
that may partition between productive folding and function on
the one hand and misfolding and aberrant protein-protein
interactions that could lead to disease progression on the other.
EXPERIMENTAL PROCEDURES
Expression and Purification of TDP-43 Fragments—Gene
fragments of TDP-43 encoding RRM1 (amino acids 102–181),
RRM2 (amino acids 190–261), an RRM2 fragment mimicking
the disease-relevant proteolytic cleavage site within RRM2 (9)
(RRM2c; amino acids 208–261), and the tethered RRMs
(tRRMs; amino acids 97–261) were purchased fromGenescript
with BamHI and EcoRI or NcoI and BamHI restriction enzyme
digestion sites. The genes were inserted into a modified pGEX-
6p1 (GE Healthcare) or pET-3d (Novagen) vector with a His6
tag and either a PreScission or TEV protease cleavage site,
respectively, for His6 tag removal. The proteins were overex-
pressed in BL21 DE3 Escherichia coli cells (Stratagene) grown
in LB medium until A600  0.8, followed by induction with 1
mM isopropyl 1-thio--D-galactopyranoside for 24 h at 20 °C
(RRM1 and tRRMs) or for 16 h at 30 °C (RRM2 and RRM2c).
Cells were resuspended in lysis buffer (20 mM NaPi, pH 7.4,
300mMNaCl, 30mM imidazole) and lysed by sonication. RRM2
and RRM2c were only present in the insoluble fraction, and
isolation from cell pellets was performed in the presence of 6 M
urea. Each construct was bound toHis60 resin (Clontech) over-
night andwashedwith 10 column volumes of lysis buffer before
elutionwith 300mM imidazole. The eluted proteinwas dialyzed
against protease cleavage buffer (50 mM Tris, pH 8.0, 1 mM
EDTA, and 1 mM DTT), followed by subsequent cleavage with
PreScission or TEV protease to remove the His6 tag. Minor
contaminantswere removed through ion exchange chromatog-
raphy using S Sepharose (RRM1) or Q Sepharose (RRM2,
tRRMs, and RRM2c) before dialysis into 10mMKPi, pH 7.2, 150
mM KCl, 1 mM -mercaptoethanol for subsequent studies.
After cleavage, protein puritywas98%, as determined by both
SDS-PAGE and reverse-phase MALDI-TOF mass spectros-
copy carried out at the Proteomics and Mass Spectrometry
Facility, University of Massachusetts Medical School.
RRM2 contains a second TEV protease-like cleavage site
(246EDLIIKG252), as determined by mass spectrometry, pre-
venting isolation of the intact domain. Thus, all RRM2-contain-
ing constructs were expressed instead with a PreScission pro-
tease site after the N-terminal His tag. Cleavage with TEV
protease (24) results in an N-terminal Gly residue before the
RRM amino acid sequence, and cleavage with PreScission pro-
tease leaves an N-terminal GPLGS sequence, with the LGS
sequence being required for cloning.
Size Exclusion Chromatography to Determine Oligomeriza-
tion State—Size exclusion chromatography was performed on
all constructs using a 24-ml Superdex 200 10/300 GL column
run at a flow rate of 0.2mlmin1. Oligomerization status of the
constructs was monitored as a function of loaded protein con-
centration by comparisonwith proteinmolecularweight stand-
ards (GE Healthcare). All size exclusion chromatography was
performed at 4 °C in 10mMKPi, pH 7.2, 150mMKCl, and 1mM
-mercaptoethanol.
Equilibrium Unfolding Experiments—The native state circu-
lar dichroism (CD) spectrum of each construct was collected
from 190 to 280 nm on a Jasco-810 spectropolarimeter with a
thermoelectric temperature control system in a 0.1-cm cuvette
(Hellma). Guanidine hydrochloride (GdnHCl)-induced dena-
turation spectra were collected from 260 to 215 nm at a scan
rate of 50 nm min1 and a response time of 8 s. Samples were
prepared from native and unfolded stock solutions mixed in
precise amounts by in-house software and a Hamilton series
500 titrator. The resulting solutions were incubated overnight
at room temperature or at 37 °C before recording CD spectra.
All GdnHCl concentrations were measured using an ABBE
refractometer, and all CD measurements were baseline-cor-
rected for buffer contributions. Protein concentration was
measured by A280 absorbance (25), using an extinction coeffi-
cient of 15,470 M1 cm1 for tRRMs, 13,980 M1 cm1 for
RRM1, and 1490 M1 cm1 for RRM2 and RRM2c. The protein
A Folding Intermediate in RRM2 of ALS-linked TDP-43
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concentration was varied from 5 to 60 M for CD experiments.
Each CD spectra was normalized for protein concentration and
number of amino acids and reported as mean residue ellipticity
(26). Reversibility was confirmed to be 95% by the coinci-
dence of equilibrium profiles for samples prepared from initial
protein stocks in either buffer or denaturant.
Steady-state fluorescence (FL) measurements were per-
formed on a Spex Fluorolog-3 equippedwith awavelength elec-
tronics temperature controller. For RRM2 and RRM2c, each
GdnHCl titration sample was excited at 274 nm, and tyrosine
emission spectra were collected from 280 to 400 nm at 20 or
37 °C with 5-nm slit widths. For the tryptophan-containing
RRM1 and tRRMs proteins, excitation was at 295 nm, and tryp-
tophan emission spectra were collected from 300 to 500 nm at
20 °C with 5-nm slit widths.
Denaturation experiments by both CD and FL were per-
formed in replicates of three for each construct to ensure repro-
ducibility. The equilibrium folding data for each construct were
analyzed using an appropriate equilibrium folding model with
the in-house data analysis software Savuka (27). Each data set
was subjected to a global analysis, where the baselines were
local parameters, and the free energy of folding in the absence
of denaturant (G0H2O) and the m value were globally linked
between data sets. All of the Trp and Tyr fluorescence equilib-
rium profiles as well as the CD equilibrium profile for RRM1
were best fit to a two-state model, N % U. For these experi-
ments, the change in free energy between the native and
unfolded states is assumed to depend linearly on the denaturant
concentration as shown in Equation 1 (28).
G  G0H2OmD] (Eq. 1)
The change in free energy in the absence of denaturant,
G0H2O, can be used to determine the equilibrium constant,
Keq, from Equation 2.
Keq  expG0H2OmD]RT  (Eq. 2)
For theCDequilibriumunfolding profiles of RRM2andRRM2c, a
three-statemodel best described the transition between the native
and unfolded forms of the protein with the population of a stable
intermediate state (I), N % I % U. Tethering the two RRM
domains by the natural 15-amino acid residue linker sequence
(tRRMs) results in the population ofmultiple stable intermediates
at equilibrium by CD. In this case, the data were best fit with a
four-state equilibriummodel, N% I1% I2%U, with the popu-
lation of two stable intermediate states, I1 and I2.
The fractional population of the intermediate state for RRM2
and RRM2c at a given denaturant concentration was deter-
mined from the partition function according to Equation 3 (29),
FI 
expGNIRT 
1 expGNIRT  expGNURT 
(Eq. 3)
whereGNIG0NIH2OmNI[D], andGNUG0NUH2O
mNU[D]. The I2 intermediate in the four-statemodel for tRRMs
corresponds to the single intermediate for RRM2, and its frac-
tional population was calculated as defined in Equation 4,
FI2 
expGNI2RT 
1 expGNI1RT  expGNI2RT  expGNURT 
(Eq. 4)
where GNI1  G0NI1  mNI1[D], GNI2  G0NI2 
mNI2[D], and GNU G0NUmNU[D].
Nucleic Acid Binding Assays—EMSAs and tryptophan (Trp)
lifetimes were used to determine the apparent binding affinity
of the TDP-43 RRM domains to UGUGUGUGUGUG ((UG)6),
TGTGTGTGTGTG ((TG)6), and TTTTTTTTTTTT (T12)
12-mer oligonucleotides (IDT Technologies). For EMSA, the
oligonucleotides were fluorescently labeled at the 5-end by
5-carboxyfluorescein (IDT Technologies).
A typical EMSA consists of 50-l reactions of 3 nM nucleo-
tides incubated with increasing protein concentrations up to 8
M. Binding reactionswere performed in binding buffer, 10mM
KPi, pH 7.2, 150 mM KCl, 2 mM DTT, 10 g ml1 tRNA, and
0.01% IGEPAL CA-630 (Sigma-Aldrich) (30) and incubated for
2 h at room temperature. Prior to loading on an 8% polyacryl-
amide gel, 5 l of bromocresol blue in 30% glycerol was added
to each reaction, and 45l of the reactionmixture was added to
the acrylamide gel. The samples were run for 1 h at 140 V in 1	
Tris-boric acid buffer followed by subsequent imaging with a
Fujifilm FLA-5000 system using a 473-nm excitation wave-
length. The fraction of bound DNA or RNA, , was measured
using Multi Gauge software (Fujifilm) to quantify the bound
fractions (upper bands) and free DNA fractions (lower bands)
from the polyacrylamide gel.
 
Bound DNA
Bound DNA Free DNA
(Eq. 5)
Trp lifetime assays were performed in 500-l reactions consist-
ing of 2 M protein incubated with increasing amounts of
nucleic acid in the EMSA binding buffer described above. The
samples were excited at 295 nm in a 50-l cuvette (Hellma)
using an autosampler configuration to prevent Trp photo-
bleaching. The laser intensity was adjusted using 4 M
N-acetyl-tryptophanamide as a standard to ensure a count rate
between 8	 104 and 1	 105 per second prior to sample acqui-
sition. Trp lifetime decays were measured for 2 min in 30-s
intervals for each sample with 
60,000 counts total in the
peak channel. The Trp lifetime decays were corrected for
buffer contributions and subsequently fit to two exponential
decays, which differed slightly, depending on protein con-
struct and DNA/RNA. In comparison with samples contain-
ing only protein, the amplitudes of the 
3.8 and 
5.8 ns
components decreased and increased, respectively, with
increased DNA/RNA concentration. Thus, the amplitude of
the faster phase represented the unbound protein, and the
slower phase resulted from the DNA/RNA-bound protein.
 
Amplitude
3.8ns
Amplitude
3.8 ns Amplitude
5.8 ns
(Eq. 6)
A Folding Intermediate in RRM2 of ALS-linked TDP-43
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The percentage bound was determined as a function of
DNA/RNA concentration and modeled to the quadratic
binding equation (Equation 7) using Igor Pro (Wavemetrics,
Inc.) to determine the apparent dissociation constant, Kd,app,
(31),
  b  m  b
	 L P kd,app) (L P kd,app)2 4LP2L  (Eq. 7)
where L is the fixed ligand concentration (for EMSA, DNA/
RNA; for Trp lifetime assays, RRM1 or tRRMs), P is the inde-
pendent variable (for EMSA, protein concentration; for Trp
lifetime assays, DNA or RNA concentration), Kd,app is the
apparent dissociation constant, and b and m are the baseline
and maximum percentage bound used to normalize the data
sets.
RESULTS
RRM Domains Are Monomeric and Well Folded—Each iso-
lated RRM domain (RRM1 and RRM2) could be expressed at
high levels, was soluble to concentrations exceeding 5mgml1
(
0.5 mM), and was monomeric by size exclusion chromatog-
raphy (Fig. 2A). Despite their structural similarity byNMR (Fig.
1, C and D), the CD spectra of the two isolated RRM domains
were strikingly different from one another. Indeed, CD spectra
can vary widely between RRM domains, including RNA-bind-
ing proteins that contain a single RRM domain, such as FUS/
TLS (32), or multiple RRM domain-containing proteins, such
as Musashi-1 (33) and U1A (34). RRM1 contains prominent
minima at 208 and 218 nm, suggesting significant -helical
propensity for this domain. RRM1 contains a dramatically
increased CD signal compared with RRM2 (Fig. 2B), consistent
in part with the enhanced -helical structure content of RRM1
FIGURE 1. TDP-43 contains both structured and disordered regions. A, domain architecture of TDP-43 and aggregation (16) and disorder (17) propensity
predictions based on the amino acid sequence. The aggregation algorithms TANGO (green) and WALTZ (blue) predict an aggregation-prone stretch in RRM2
(residues 228–233), with WALTZ predicting a second region in the glycine-rich domain (residues 314–319) and TANGO predicting a region near the nuclear
localization sequence (NLS; purple). The disorder algorithm PONDR (orange) predicts high amounts of disorder in the C-terminal glycine-rich region (orange),
where the ALS-causing mutations are located. Regions of disorder are also predicted in the linker, which lies between the two RRM domains as well as within
the nuclear localization sequence. By contrast, very little disorder is predicted within the putative NES (yellow). B, the two RRM domains show high sequence
similarity by ClustalW2 sequence alignment (*, identical; :, similar). Residues in -strands and -helices are colored blue and red, respectively, with the residues
removed in RRM2c boxed in cyan. The predicted aggregation prone sequence in3 is highlighted in boldface type, and the putativeNES sequence is underlined.
C and D, RRM domains are structurally similar based on solution NMR (C, RRM1 (Protein Data Bank entry 2cqg); D, RRM2 (Protein Data Bank entry 1wf0)).
-Strands are colored blue, -helices are red, and loops are gray. The key phenylalanine residues identified for RNA binding in 3 are shown as sticks (RRM1,
Phe147 and Phe149; RRM2, Phe229 and Phe231), and intrinsic fluorophores for following tertiary structure folding are also shown (RRM1, Trp113 and Trp172; RRM2,
Tyr214). The RRM2c construct, a model for the cleavage observed in disease, removes the first -strand and half of the first -helix (deleted regions shown in
cyan) in RRM2. Note that the solution structure of RRMc is unknown and predicted to bemuch different from that mapped on RRM2 (Protein Data Bank entry
1wf0) due to removal of secondary structural elements in the protein core. E, NMR structure of the tethered RRMswith RNA (ProteinData Bank entry 4bs2)with
RNA shown in gray (43). The secondary structure elements are colored as shown in C andD. The RNA-binding residues and intrinsic fluorophores are shown as
sticks.
A Folding Intermediate in RRM2 of ALS-linked TDP-43
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(25%) compared with RRM2 (20%), as predicted by DSSP (35,
36), based on the NMR structures (Fig. 1B). The CD spectrum
of RRM2 was approximately half as intense as that of RRM1,
with aminimum at 210 nm and a shoulder at 230 nm. Although
the two RRM domains have identical -strand content (30%),
the NMR structures indicate that RRM1 has more twist to its
-sheet compared with RRM2, consistent also with the
increased intensity of the CD signal for RRM1 (37).
RRM2 Populates an Intermediate State—To probe the equi-
librium folding mechanism of the RRM domains and its poten-
tial role in ALS, denaturant-induced unfolding was used to
sample other protein conformations. The loss in secondary and
tertiary structure was monitored by CD and FL, respectively
(Fig. 3, A and B). Initial equilibrium folding studies performed
in urea (data not shown) showed that RRM2 remains partially
folded at high urea concentrations (8 M). By contrast, both
RRM1 and RRM2 were fully unfolded in the presence of 7.5 M
GdnHCl.
RRM1 has a CD spectrum with two prominent minima (Fig.
2B) characteristic of an    protein. The two tryptophan
residues, unique to RRM1 (Fig. 1C), monitor the tertiary struc-
turewithin this domain upon unfolding. For RRM1 at 20 °C, the
CD and Trp FL reveal a single cooperative transition between
the native folded state and the unfolded state (Fig. 3A) that is
well described by a two-state model for the free energy of fold-
ing in the absence of denaturant; G0H2O  3.7 kcal mol1
(Table 1). The midpoints (Cm) of the transition between these
two states are coincident between the two spectroscopic tech-
niques (Fig. 4,A and B), consistent with a two-state mechanism
of folding for the RRM1 domain.
In comparison with RRM1, RRM2 contains reduced elliptic-
ity and a single tyrosine as a fluorescence probe. The unfolding
profile of RRM2 at 20 °C (Fig. 3B) monitored by CD is signifi-
cantly different from that of RRM1. A change in the coopera-
tivity observed at 4 M GdnHCl indicates a three-state unfolding
process with contributions from a stably populated intermedi-
ate state. The transitions in the N% I% U three-state mecha-
nism contribute 3.6 kcal mol1 (N% I) and 3.8 kcal mol1 (I%
U) to the total stability of RRM2 (Table 1; 7.4 kcal mol1). The
CD and FL transitions are not coincident, further supporting
the presence of an intermediate state on the RRM2 unfolding
pathway. TheTyr fluorescence becomes insensitive to denatur-
ant in the second transition (4 M GdnHCl), suggesting that
the region surrounding this residue is unfolded in the interme-
diate state. Using the thermodynamic parameters for the indi-
vidual transitions (N % I and I % U), the population of the
intermediate state was calculated as a function of denaturant by
Equation 3. As shown in Fig. 4C, the intermediate state is max-
imally populated (80%) at 4 M GdnHCl, and a small proportion
(1%) of RRM2 populates this partially unfolded intermediate
state under native conditions (0 M GdnHCl).
Intermediate Population Is Enhanced by Increased Tempera-
ture or Cleavage of RRM2—InALS patient tissues, fragments of
TDP-43 comprising the C terminus and regions of RRM2 are
present in cytoplasmic inclusions (9). One of these fragments of
RRM2, starting at position Arg208, results in the removal of 1
and a region of 1 and leads to severe aggregation and toxicity
in cell models (12, 13, 15). The disruption of the native fold in
RRM2c could enhance the population of partially unfolded
states. A construct consisting of residues 208–261 (RRM2c) of
RRM2 was designed, cloned, and expressed for denaturation
studies. RRM2c rapidly precipitates from solution upon the
addition of salt, suggesting that RRM2c adopts a structure that
facilitates aggregation under cellular ionic strength conditions
(38). The fragment was predominantly monomeric by size
exclusion chromatography (Fig. 2A); however, to enhance the
solubility of RRM2c in the absence of denaturation, the 150mM
KCl was eliminated from the folding buffer.
The CD spectrum of RRM2c reveals that cleavage within the
domain greatly reduces but does not obliterate its secondary
structure (Fig. 2B). The fragment retains the three-state behav-
ior of the RRM2 domain upon denaturation at 20 °C (Fig. 3D)
and significant stability (Table 1; 4.1 kcal mol1). The transi-
tions (N % I and I % U) are destabilized compared with the
FIGURE 2. The isolated RRMdomains aremonomeric and contain significant secondary structure under physiological salt conditions.A, analytical size
exclusion chromatography of the isolated (green, RRM1; blue, RRM2; orange, RRM2c) RRM domains reveals that each isolated domain is predominantly
monomeric. The tethered domains (tRRMs, black) are also predominantly monomeric; however, some higher order species are also present, probably due to
domain swapping. The arrows indicate retention times ofmolecular weight standards. B, RRM1 contains significant secondary structure comparedwith RRM2.
RRM1 (green) has a minimum at 218 nmwith a shoulder at 208 nm, whereas RRM2 (blue) has reduced ellipticity with a minimum at 210 nm and a shoulder at
220 nm. The cleavage fragment, RRM2c (orange) has further reduced ellipticity. All CD spectra were taken at 20 °C unless otherwise noted; physiological
temperature (37 °C) does not alter the secondary structures of RRM2 (red) or RRM2c (purple). Tethering the RRMs (tRRMs; black) results in a CD spectrum
resembling the sum of the isolated domains (black dashed line). The CD spectrum for each protein, reported as mean residue ellipticity as a function of
wavelength, did not vary in the range of 5–60 M, and all proteins showed similar unfolded spectra when denatured in 7 M GdnHCl (blue dashed line).
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intact domain (Table 1) and display non-coincident CD and
tyrosine FL transitions that support a three-state unfolding
model for RRM2c. The FL results suggest that the fragment can
fold to a conformation that decreases the solvent accessibility of
the Tyr, although the Tyr is close to the newN terminus. Com-
paring the fraction species plot of the intermediate state as a
function of denaturant reveals that 2% of the RRM2c confor-
mational ensemble samples the intermediate state under native
conditions at 20 °C (Fig. 4B, compare orange and blue traces).
These results indicate that fragments of RRM2 sample partially
folded states to a greater extent than the intact domain andmay
provide a platform for subsequent TDP-43 aggregation (38).
Incubation of RRM1 at physiological temperatures (37 °C)
resulted in aggregation (39, 40), whereas RRM2 and RRM2c
FIGURE 3. The isolated and tethered RRMdomains have complex equilibriumunfolding profiles at 20 °C. A, equilibrium unfolding of RRM1 unfolds by a
two-statemechanism (N%U)bybothCD (filled circles, solid line) andTrpFL (open circles,dashed line).B, RRM2unfolds through thepopulationof anequilibrium
intermediate (N% I%U) by CD (filled triangles, solid line). By contrast, the Tyr FL (open triangles, dashed line) unfolds in a two-state process that coincides with
the N% I transition observed by CD. C, tethering the two RRMs stabilizes the RRM1 transition, resulting in a complex equilibrium unfolding profile with two
stable intermediate states (N% I1% I2%U) by CD (closed diamonds, solid line). Trp FL (open diamonds, dashed line) follows the denaturation of RRM1 only and
coincides with the first transition (N% I1) by CD.D, a cleavage fragment of RRM2 (RRM2c) unfolds through a three-statemechanism by CD (filled squares, solid
line) with destabilization of both transitions compared with RRM2. Similar to RRM2, the two-state transition observed by Tyr FL (open squares, dashed lines)
coincides with the N% I transition by CD. Each experiment was consistently reproduced three times.
TABLE 1
Thermodynamic parameters of the isolated and tethered RRM domains
The CD or FL experiments for the appropriate RRM construct were fit to an appropriate model: 1) two-state (N% U), 2) three-state (N% I% U), or 3) four-state (N%
I1% I2%U)with the corresponding free energy in the absence of denaturant (G0),m value (m), andmidpoint (Cm) for each transition. Them value correlates to the buried
surface area of each domain, and the Cm is the denaturant concentration where the domains populate two states equally. The total G0 andm value for each construct are
reported in the right-most column. Units: G0 (kcal mol1),m(kcal mol1 M1), and Cm (M). Each experiment is an average of three (n 3) independent trials.
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remain in native conformations (Fig. 2B) with little change in
secondary structure. Denaturation of the intact RRM2 at 37 °C
(Fig. 4C) also follows a three-state unfolding process, albeit with
a reduction in the overall stability (5.7 versus 7.4 kcalmol1). As
with denaturation of RRM2 at 20 °C, the Tyr FL data were not
coincident with the CD data (Table 1), supporting the presence
of an intermediate in RRM2even at elevated temperatures. Sur-
prisingly, denaturation of RRM2c at 37 °C revealed a three-state
unfolding profile coincident with the intact domain (Fig. 4B)
but with a slight increase in total stability upon increasing tem-
perature (4.1 versus 4.8 kcal mol1). The increase in overall free
energy suggests either a self-association of RRM2c or that the
folding of this fragment is driven by the hydrophobic effect,
which is stronger at higher temperatures (41, 42). Self-associa-
tion is concentration-dependent, and thus higher concentra-
tion would be expected to drive the association reaction and
stabilize the protein against denaturation. However, our exper-
iments revealed no concentration dependence for the unfold-
ing transition by CD in the range from 15 to 60 M RRM2c.
Further, the lack of denaturant dependence of the tyrosine
emission spectrum for RRM2c shows that the Tyr is exposed to
solvent in this RRM2 fragment at physiological temperatures
(Fig. 4E). This conformation differs from the Tyr FL at 20 °C,
where the Tyr is at least partially buried in the native RRM2c
structure. The destabilized native conformations of bothRRM2
andRRM2c at physiological temperature suggest that the inter-
mediate state becomesmore populated under native conditions
at increased temperatures. Indeed, the intermediate state is
5–10-fold more populated at 37 °C compared with 20 °C for
both the intact RRM2 and the fragment of RRM2. Together,
these results show that either a cleavage event within the RRM2
domain or physiological temperature increases the population
of a potentially pathological intermediate state that may con-
tribute to possible misfolding and aggregation.
Tethering the RRMDomains Results in Stabilization of RRM1
and Decreased Access to the RRM2 Intermediate—Under nor-
mal cellular conditions, the RNA binding domain of TDP-43
consists of RRM2 tethered to RRM1 by a short 15-amino acid
linker. As such, the presence of RRM1may influence the folding
of RRM2 through mutual stabilizing interactions and decrease
the population of the RRM2 intermediate state. The tRRMcon-
struct, which comprises RRM1, RRM2, and its natural linker,
exhibits a CD spectrum that is very similar to the additive sum
of the individual RRM domain spectra (Fig. 2B). This observa-
FIGURE 4. Cleavage and physiological temperatures destabilize RRM2 and increase the population of the intermediate state. A, fraction apparent plot
of the Trp FL of RRM1 (open circles, green dashed line) and tRRMs (open triangles, black dashed line) at 20 °C reveals a shift toward higher denaturant for RRM1
unfoldingupon tethering toRRM2.B, fractionapparentplotsof all TDP-43RRMconstructsbyCD.RRM1displays a two-stateequilibriumprofile (green),whereas
RRM2 (20 °C,blue; 37 °C, red) and the cleavage fragment, RRM2c (20 °C,orange; 37 °C,purple) display a three-stateprofilewith thepopulationof an intermediate
state. tRRMs (black) display a complex unfolding profile with the population of two stable intermediates. C, RRM2 intermediate population as a function of
denaturant using Equation 3 for a three-state profile (RRM2 and RRM2c) or Equation 4 for a four-state profile (tRRMs). Increasing temperature (red) or cleavage
(orange and purple) within the RRM2 domain (blue) results in an increased intermediate population under native conditions (0 M GdnHCl) with a shift to lower
denaturant for the maximum intermediate population. Tethering RRM2 to RRM1 (black) reduces the RRM2 intermediate state under native conditions and
shifts the maximum population to higher denaturant. D, physiological temperatures destabilize the N% I transition by CD (filled inverted triangles, solid line)
and Tyr FL transition (open inverted triangles, dashed line) with a shift in the Cm to lower denaturant comparedwith RRM2. E, physiological temperature results
in a similar unfolding profile for RRM2c to RRM2 at 37 °C (compare filled inverted triangleswith filled hexagons). Tyr FL revealed little changebetween the folded
and unfolded states (open hexagons), suggesting that Tyr214 resembles the unfolded state at this temperature. Each experiment was consistently reproduced
three times.
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tion suggests that tethering the two RRM domains does not
significantly affect the overall secondary structure of each
RRM. The slight differencesmay arise through a small decrease
in -helical content of the RRM1 domain when tethered, as
suggested by the decrease in the 190 nm band and the shift in
the ratio of the CD signal at 222 nm to 208 nm for tRRMs
compared with the additive spectra (Fig. 2B).
However, upon denaturation with GdnHCl, tRRMs dis-
played a complex equilibrium unfolding profile when moni-
tored by CD that was best described by N % I1 % I2 % U,
suggesting the population of two discrete intermediate states
(Fig. 3C). To elucidate the extent that each RRM domain con-
tributes to the intermediates, the Trp FL data were used as a
constraint to define the first transition. Because Trp residues
are only present within RRM1, the Trp FL provides structural
insights into the unfolding of only RRM1 when tethered to
RRM2. Interestingly, comparison of the Trp FL of the isolated
RRM1 with the tethered RRMs (Fig. 4A) reveals a shift in the
transition midpoint (Cm) to higher denaturant (from 1.5 to 2.3 M)
upon tethering. These results suggest that RRM1 and RRM2
interact in the absence of RNA, with interdomain interactions
stabilizing the native state of each RRM domain by 0.9 kcal
mol1 (Table 1). Indeed, a recent NMR study on the tethered
RRM domain revealed that in the absence of RNA, the two
RRMsdonot tumble independently of one another (43), further
supporting mutual stabilizing interactions between the
domains. The Trp FL also suggests that RRM1 is completely
unfolded at the first intermediate, I1, of the CD equilibrium
unfolding profile. The extent of the RRM2 folding at the I1
intermediate is unclear because this domain lacks Trp residues,
and the contributions from the single tyrosine residue are
masked by RRM1. However, the thermodynamic parameters
derived from the CD profile suggest that RRM2 is at least par-
tially unfolded because the I1% I2 transition of tRRMs is not
coincident with N% I of RRM2 (Fig. 4B).
The third transition in the equilibrium profile of tRRMs
(I2%U) corresponds to the I%U transition of RRM2 (Table 1)
because both transitions provide similar stability and mid-
points. Therefore, the I2 species in the tethered domains prob-
ably correspond to the same RRM2 intermediate state. Using
Equation 4 to identify the population of the RRM2 intermediate
as a function of denaturant reveals that tethering shifts the
maximal population of RRM2 to higher denaturant (5.0 M
GdnHCl) compared with the individual RRM2 domain (4.0 M
Gdn; Fig. 4C), suggesting that RRM1 inhibits the formation of
the RRM2 intermediate. Indeed, based on the stability mea-
surements from the four-state model, RRM1 contributes
0.7
kcal mol1 of stability to the RRM2 native state, which would
shift the N% I transition to higher denaturant concentration
and reduce the intermediate state population under native con-
ditions. These results suggest that in the intact TDP-43 with
RRM2 tethered to RRM1, mutual interactions between these
domains can serve two purposes: 1) stabilizing RRM1 against
populating unfolded conformations and 2) decreasing the
RRM2 intermediate to almost negligible populations under
native conditions (0.1%). Isolating or fragmenting RRM2
removes stabilizing contributions from RRM1 and allows this
region of TDP-43 to sample a potentially pathogenic partially
folded state.
RRM2 Binds Weakly to RNA and Enhances RRM1 Affinity—
TDP-43 is involved in multiple RNA processes, and thus, RNA
probably plays a role in the folding and stability of the RRM
domains. As shown in Fig. 4A, RRM1 becomes stabilized
against denaturationwhen the twoRRMs are tethered, suggest-
ing that this interaction could also enhance the affinity of RRM1
and possibly RRM2 for RNA. Two complementary nucleic acid
binding assays, EMSA (Fig. 5A) and the tryptophan lifetime-
based assay (Fig. 5B), were used to determine the dissociation
constant,Kd,app, for each individual and tethered RRMdomain.
Based on the results of previous binding affinity measurements
on various TDP-43 constructs (21), the oligonucleotides (UG)6
and (TG)6 were selected for comparing the affinities of each
domain, and T12 was selected as a control oligonucleotide.
In the EMSA, RRM2 bound to the UG repeat sequence very
weakly with a dissociation constant of 17.0 M (Table 2). Strik-
ingly, RRM2c had a binding affinity forUG repeats enhanced by

5-fold compared with the intact domain. This enhancement
indicates that RRM2c may access conformations that favor
RNA binding compared with the intact RRM2 domain. Inter-
actions with DNAweremuch weaker than for RNA (100M)
and unmeasurable by EMSA. This weak binding of RRM2 and
RRM2c to RNA suggests that these domains may serve to sta-
bilize RRM1 (Fig. 4A) rather than provide a major contribution
to RNA binding. In fact, RRM1 binds with a Kd,app in the nano-
molar range compared with the micromolar range of RRM2
FIGURE 5. Tethering the RRM domains enhances the RNA binding affinity
comparedwith RRM1.A, EMSAof increasing concentrations of RRM1 (top) and
tRRMs (bottom) to a fixed concentration of 5-carboxyfluorescein (FAM)-labeled
(UG)6. Theupperand lowerbandson thenativepolyacrylamidegel represent the
bound and free fractions of labeled RNA, respectively. B, Trp lifetimes of RRM1
alone (black) or bound by (UG)6 (gray) reveal a decrease in lifetime in the Trp on
RRM1 upon binding. Trp lifetimes are insensitive to RRM2 due to a lack of Trp in
this domain. Trp lifetimeswere performed as a function of nucleic acid to a fixed
concentrationof RRM1and tRRMs.C, quantificationof the EMSA. Eachdata set is
an average of three independent runs and modeled to the quadratic binding
equation (Equation 6). A complete summary of binding affinities for tRRMs,
RRM1, RRM2, and RRM2c is provided in Table 2.
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(Table 2), supporting RRM1 as the major contributor to RNA
binding. Notably, tethering the two RRM domains enhances
binding affinity by an order of magnitude to result in dissocia-
tion constants for UG and TG repeat sequences in the low
nanomolar range (Fig. 5C and Table 2). Trp lifetimes on the
RRM domain reveal a reduction of Trp intensity and lifetime
uponbindingRNA (Fig. 5B) and provide structural insights into
the binding interaction because the Trp residues are located on
the -sheet of RRM1. The RNA binding results suggest that the
presence of RNA will play a role in defining the populations of
all species on the folding free energy surface of TDP-43 by sta-
bilizing the RRM domains and modulating access to the par-
tially folded state in RRM2.
DISCUSSION
Although the ALS-linked proteins, such as SOD1 (44), TDP-43
(45, 46), FUS/TLS (47), profilin 1 (48), and C9ORF72 (49, 50)
among others (51), are functionally different, common mecha-
nisms for cellular toxicity and aggregationmay govern the folding
pathways of these proteins to result in disease. Indeed, the RNA-
bindingproteins,TDP-43andFUS/TLS,havebeen linkednotonly
to ALS but also to other neurodegenerative diseases, including
FTLD-U (1), Alzheimer disease (52), and Parkinson disease (53),
suggesting a potential commonmechanismof disease pathogene-
sis between these proteins. Here, we performed denaturation and
RNAbinding studies toprobe the equilibriumunfoldingpathways
of the isolated and tethered RRM domains of TDP-43. The data
revealed a highly populated stable folding intermediate within
RRM2 (Figs. 3B and 4C) that may link the pathways governing
TDP-43 folding and function with those of misfolding and aggre-
gation. Specifically, the intermediate state may have a normal cel-
lular function in nuclear export, but at the same time, populating
this intermediate state may sow the seeds for misfolding and
aggregation in disease.
A major focus of the TDP-43 field has been to investigate the
potential impacts of TDP-43 loss-of-function and aggregation
propensity on the propagation of ALS and FTLD (1, 8, 11, 54, 55).
Aggregation studies on RRM2 revealed increased formation of
fibrillar aggregates with truncated RRM2 and peptide fragments
consisting of 3 and 5 (56). These results suggest that the core
sequences within RRM2 may directly participate in driving the
aggregation of TDP-43. TANGO and WALTZ (16) predict an
aggregation-prone region, 3 (Fig. 1A), localized within RRM2
thatmay serve as a template for aggregation propagation. In com-
bination with the C terminus, intact or fragmented RRM2 was
shown to severely enhance cellular aggregation and toxicity in cell
models (12, 13, 15, 38, 57). The C terminus, which also contains a
particularly aggregation-prone stretch (Met311–Met323), was
shown to have increased -strand propensity and aggregation
tendency (38), whereas a Gln/Asn-rich region that is critical for
properTDP-43protein-protein interactionswas also sufficient for
aggregation of GFP fused with multiple Gln/Asn repeats (58).
Taken together, these results suggest that the population of the
RRM2 intermediate state could expose aggregation-prone resi-
dues, such as 3 and 5 (56), either through the intact domain,
cleavage by caspases (13, 59–61), or increased temperatures. This
partially folded state could aberrantly interactwithRRM1 (39, 62),
the aggregation-prone C-terminal peptides (56, 63), or potential
sequences within other proteins, such as heterogeneous nuclear
ribonucleoprotein A1 and A2/B1 (64, 65), to promote misfolding
and propagate the aggregation observed in ALS and FTLD
patients.
Biophysical studies on TDP-43 have been hindered by the poor
solubility and aggregation tendencies of the full-length protein.
Thermal denaturation studies have shown that RRM2 remains
well folded and resistant to denaturation beyond 85 °C, whereas
RRM1undergoes a conformational change at 50 °C (38, 66).These
results suggest an inherent stability difference between the two
domains, which are 30% identical in sequence by ClustalW2 (Fig.
1B). Similarly, in our study, the GdnHCl-induced denaturation of
these domains revealed markedly different equilibrium unfolding
profiles with significantly different stabilities (Table 1). GdnHCl
denaturation fortuitously revealed a partially folded state that was
not evidentby thermaldenaturation.Thus, chemicaldenaturation
provides access to a partially folded state that may be relevant for
both function and aggregation.
Hydrogen exchange experiments on the TIM barrel protein
family have shown that clusters of isoleucine, leucine, and
valine residues can accurately predict cores of stability (67) and
early folding events (68, 69). Using an in-house algorithm (see
the Clusters of Branched Aliphatic Side Chains in Globular
Proteins (BASiC) Web site) (70, 71)), clusters of the branched
aliphatic side chain residues in RRM1 (Fig. 6D) and RRM2 (Fig.
6A) were identified using the NMR structures. As shown in Fig.
6, RRM2 contains one large cluster with 12 ILV residues, eight
ofwhich providemultiple contacts (Fig. 6C). RRM1 (Fig. 6E), on
the other hand, contains three clusters of ILV residues with two
single-contact clusters and a remaining cluster that consists of
eight loosely connected residues. Upon tethering to RRM2 and
the addition of RNA, the Leu106-Leu177 contact (Fig. 6,D and E,
purple) andVal161 in2 are incorporated into theRRM1cluster
and possibly enhance the stability of RRM1. InRRM2c (Fig. 6B),
three ILV residues (Val193, Val195, and Leu207) (Fig. 5D, cyan)
are removed, and the remaining contacts may provide a signif-
icantly different hydrophobic core for folding (Fig. 2A). This
networked cluster of ILV residues in RRM2 and RRM2c (Fig.
6C) probably contributes to the presence of a stable intermedi-
ate and increased stability of RRM2 compared with RRM1 (Fig.
6E).
Alternatively, the RRM2 intermediatemay serve a functional
role in RNA processing. Normal TDP-43 shuttling to the cyto-
plasm is probably governed by a leucine-rich NES (72) located
within RRM2 (residues 239–250). Alanine mutation of any of
TABLE 2
Dissociation constants of the isolated and tethered RRM domains
Shown are the dissociation constants of each construct by an EMSA and Trp life-
times (FL) for RRM1, RRM2, RRM2c, and tRRMs to (UG)6, (TG)6, and T12. FL
assays were only performed on RRM1 and tRRMs, whereas an EMSA was suitable
for all constructs. Each experiment is an average of three independent experiments.
RRM domain Assay
Dissociation constant
(UG)6 (TG)6 T12
nM nM nN
RRM1 EMSA 49.3 12.0 232 48 8000
FL 34.8 14.1 630 75 100,000
RRM2 EMSA 17,000 3700 100,000 100,000
RRM2c EMSA 2750 480 100,000 100,000
tRRMs EMSA 3.1 1.3 20.2 1.8 8000
FL 3.2 2.2 279 90 100,000
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the hydrophobic residues within this sequence resulted in
nuclear mutants and endogenous aggregates (73). The NES
forms 2 and 4 within RRM2 to possibly sequester the hydro-
phobic residues (Leu243, Leu248, and Ile250) and contribute to
the ILV cluster (Fig. 6B). Another ALS-linked protein, FUS/
TLS, also contains a NES within an RRM domain (74) with low
affinity for RNA (75). Strikingly, we have observed that the
RRM domain of FUS/TLS also unfolds through an equilibrium
intermediate state.3 The presence of an intermediate state in
the RRMunfolding pathways of TDP-43 and FUS/TLS suggests
that these RRMs may serve to stabilize the other RNA-binding
domain and sequester the NES within the hydrophobic core to
control cytoplasmic shuttling or to prevent aggregation. RRM2
must partially unfold to expose the NES for recognition by
exportin (76), which mediates the transport to the cytoplasm.
This hypothesis suggests that cleavage within RRM2, loss of
RRM1, or external stressors would increase the population of
the intermediate state and disrupt the normal cellular distribu-
tion. Up-regulated export to the cytoplasm could increase the
formation of dysfunctional complexes with other proteins and
cytoplasmic aggregates that would ultimately decrease the pop-
ulation of functional nuclear TDP-43. Further experiments to
investigate the role of the intermediate state onTDP-43 nuclear
export would delineate the consequences of populating this
partially folded state.
RRM2 may also enhance the function of TDP-43 through
interactions with RRM1 and RNA. Tethering RRM2 to RRM1
increases the stability of RRM1 (Fig. 4C) and the affinity to
UG-rich sequences (Fig. 5C). Studies onRNAbinding in disease
progression have indicated that removal of RRM1 or muta-
tional analysis of key phenylalanine residues in RRM1 results in
non-functional TDP-43 with neurotoxicity and aggregation
phenotypes (21–23, 77, 78). A cell-free system revealed that
incubation with (UG)6 or (TG)6 resulted in an increase in
TDP-43 solubility and reduced the tendency to aggregate com-
pared with mutant RRM1 TDP-43 (22). These results suggest
3 B. C. Mackness, M. T. Tran, S. P. McClain, C. R. Matthews, and J. A. Zitzewitz,
unpublished data.
FIGURE 6.Extensive andnetworked ILV cluster in RRM2.A, solutionNMR structure of RRM2 (ProteinData Bank code 1wf0)with isoleucine (I), leucine (L), and
valine (V) residues highlighted that contact other ILV residues (blue). B, residues from the large cluster in RRM2 that are removed in RRM2c are highlighted in
cyan, and the NES (residues 239–250), which is still part of the large cluster in RRM2c, is highlighted in yellow. C, ILV cluster contact map for RRM2 displayed on
the secondary structure elements of RRM2. The RRM2 ILV cluster contains a single highly connected cluster (blue) spanning all-helices and-strands, and the
cluster is unaffected by tethering to RRM1. The residues removed in RRM2c (cyan) are marked with an asterisk. The NES (yellow) contributes three residues to
the large ILV cluster (Leu243, Leu248, and Ile250), whichmay contribute to the increased stability of RRM2 comparedwith RRM1.D, RRM1 (ProteinData Bank code
2cqg) contains three small clusters (purple, red, and green), two of which were single surface residue contacts (red and purple). The remaining cluster (green) is
small and less connected comparedwithRRM2. E, theRRM1cluster contains a small ILV clusterwith single contacts centered in1–3.Upon tethering toRRM2
and RNA binding, the cluster exhibits a few contact changes that include the addition of Val161 and the purple cluster, resulting in a more networked RRM1
compared with the isolated RRM1.
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that RNA binding may be playing a critical role in limiting
access to the partially folded intermediate in RRM2 and reduc-
ing aggregation. RNA binding assays by our group and others
(21, 66) suggest that RRM2 binds weakly to RNA compared
with RRM1 (Table 2). RRM2 could contribute to RNA binding
through twopotentialmechanisms: 1) RRM2may contribute to
binding through allosteric interactions with RRM1, and 2)
RRM2 may indirectly contribute to binding by stabilizing
RRM1. In either scenario, mutual interactions between RRM1
and RRM2 would reduce access to the RRM2 intermediate
state. Structural information on the DNA/RNA-bound teth-
ered domains would provide critical insights into the RNA-
binding modes for each of these domains and could further
delineate the role of RNA in the RRM folding pathway.
The thermodynamic and DNA/RNA binding experiments
suggest a mechanism for potential TDP-43 dysfunction and
aggregation through the RRM2 intermediate (Fig. 7). Normal
cellular TDP-43 is involved in multiple RNA processes with
protein partners in the nucleus. TDP-43probably exists in equi-
librium between two states: the folded TDP-43 and functional
TDP-43 that populates the RRM2 intermediate. This interme-
diate could serve two potential roles: 1) a productive functional
intermediate allowing for NES recognition by the cellular
export machinery or 2) a non-productive misfolding interme-
diate with exposed aggregation-prone peptides, such as 3 and
5, that may aberrantly interact with other intact and frag-
mented TDP-43 as well as other known protein partners. Nor-
mally, only a small fraction of TDP-43 populates the interme-
diate state, and the equilibrium heavily favors the folded
TDP-43 with a properly folded RRM2. The NES remains
sequestered in the hydrophobic core of the molecule for the
nuclear localization of TDP-43.However, cellular stresses, such
as oxidative damage, could result in TDP-43 cleavage and loss
in RNA binding or protein partners. Such events could poten-
tially shift the equilibrium toward the misfolding of the inter-
mediate state. These misfolded, non-functional proteins may
increase transport to the cytoplasm, where exposure of the
hydrophobic residues in the NES or aggregation-prone pep-
tides in RRM2 results in the formation of dysfunctional com-
plexes and aggregates of TDP-43. In any case, the reduced func-
tional pool of TDP-43 in the nucleus would influence neuronal
death. Thus, the RRM2 intermediate statemay link the produc-
tive folding and function of TDP-43 with non-productive mis-
folding and aggregation that leads to disease progression. Ther-
apeutic intervention strategies can be developed that take into
account approaches that limit pathological access to this inter-
mediate state, potentially offering a viable drug target for treat-
ing ALS and FTLD.
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